By Laura Donnelly, Health Editor 7:00AM BST 09 Jun 2014
Tens of thousands of Multiple Sclerosis sufferers could be denied drugs which can stop sufferers “screaming out” in pain, under new NHS recommendations, experts have warned.
Neurologists said the decision by the National Institute of Health and Care Excellence (Nice) to reject two cannabis-based drugs for symptoms of MS could leave thousands of patients suffering “horrendous” pain and immobility.
New draft guidelines on the diagnosis and care of people with MS have rejected two drugs which have been licensed in recent years to help sufferers experiencing spasticity and mobility problems.